Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
Clinical trial NCT06191315 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06191315
- Sponsor
- Sanofi
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2028-12-21
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.